Tetsuo Tsukamoto

Prof. Tetsuo Tsukamoto

Niigata University of Health and Welfare, Niigata, Japan
orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 November 2019 in Mucosal Immunology
Verified
Journal Article
Closed access
PDF file
PDPaul R. Dunbar
Paul R. Dunbar
ECEmily K. Cartwright
Emily K. Cartwright
AWAlexander N. Wein
Alexander N. Wein
TTTetsuo Tsukamoto
Tetsuo Tsukamoto
ZLZheng-Rong Tiger Li
Zheng-Rong Tiger Li
JKJacob E. Kohlmeier
Jacob E. Kohlmeier

15 October 2008 in Journal of Virology
Verified
Journal Article
Closed access
MKMiki Kawada
Miki Kawada
TTTetsuo Tsukamoto
Tetsuo Tsukamoto
HYHiroyuki Yamamoto
Hiroyuki Yamamoto
NINami Iwamoto
Nami Iwamoto
KKKyoko Kurihara
Kyoko Kurihara
TMTetsuro Matano
Tetsuro Matano
Gag-specific cytotoxic T lymphocytes (CTLs) exert strong suppressive pressure on human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV) replication. However, it has remained unclear whether they can actually contain primary viral replication. Recent trials of prophylactic vaccines inducing virus-specific T-cell responses have indicated their potential to confer resistance against primary SIV replication in rhesus macaques, while the immunological determinant for this vaccine-based viral control has not been elucidated thus far. Here we present evidence implicating Gag-specific CTLs as responsible for the vaccine-based primary SIV control. Prophylactic vaccination using a Gag-expressing Sendai virus vector resulted in containment of SIVmac239 challenge in all rhesus macaques possessing the major histocompatibility complex (MHC) haplotype 90-120-Ia . In contrast, 90-120-Ia -positive vaccinees failed to contain SIVs carrying multiple gag CTL escape mutations that had been selected, at the cost of viral fitness, in SIVmac239-infected 90-120-Ia -positive macaques. These results show that Gag-specific CTL responses do play a crucial role in the control of wild-type SIVmac239 replication in vaccinees. This study implies the possibility of Gag-specific CTL-based primary HIV containment by prophylactic vaccination, although it also suggests that CTL-based AIDS vaccine efficacy may be abrogated in viral transmission between MHC-matched individuals.

15 May 2007 in Journal of Virology
Verified
Journal Article
Open access
MKMiki Kawada
Miki Kawada
TTTetsuo Tsukamoto
Tetsuo Tsukamoto
HYHiroyuki Yamamoto
Hiroyuki Yamamoto
ATAkiko Takeda
Akiko Takeda
HIHiroko Igarashi
Hiroko Igarashi
TMTetsuro Matano
Tetsuro Matano
Induction of virus-specific CD8(+) cytotoxic T-lymphocyte (CTL) responses is a promising strategy for AIDS vaccine development. However, it has remained unclear if or how long-term viral containment and disease control are attainable by CTL-based nonsterile protection. Here, we present three rhesus macaques that successfully maintained Env-independent vaccine-based control of simian immunodeficiency virus (SIV) mac239 replication without disease progression for more than 3 years. SIV-specific neutralizing antibody induction was inefficient in these controllers. Vaccine-induced Gag-specific CTLs were crucial for the chronic as well as the primary viral control in one of them, whereas those Gag-specific CTL responses became undetectable and CTLs specific for SIV antigens other than Gag, instead, became predominant in the chronic phase in the other two controllers. A transient CD8(+) cell depletion experiment 3 years postinfection resulted in transient reappearance of plasma viremia in these two animals, suggesting involvement of the SIV non-Gag-specific CTLs in the chronic SIV control. This sustained, neutralizing antibody-independent viral control was accompanied with preservation of central memory CD4(+) T cells in the chronic phase. Our results suggest that prophylactic CTL vaccine-based nonsterile protection can result in long-term viral containment by adapted CTL responses for AIDS prevention.

15 February 2006 in Journal of Virology
Verified
Journal Article
Open access
PDF file
MKMiki Kawada
Miki Kawada
HIHiroko Igarashi
Hiroko Igarashi
ATAkiko Takeda
Akiko Takeda
TTTetsuo Tsukamoto
Tetsuo Tsukamoto
HYHiroyuki Yamamoto
Hiroyuki Yamamoto
TMTetsuro Matano
Tetsuro Matano
Cytotoxic T-lymphocyte (CTL) responses are crucial for the control of immunodeficiency virus replication. Possible involvement of a dominant single epitope-specific CTL in control of viral replication has recently been indicated in preclinical AIDS vaccine trials, but it has remained unclear if multiple epitope-specific CTLs can be involved in the vaccine-based control. Here, by following up five rhesus macaques that showed vaccine-based control of primary replication of a simian immunodeficiency virus, SIVmac239, we present evidence indicating involvement of multiple epitope-specific CTL responses in this control. Three macaques maintained control for more than 2 years without additional mutations in the provirus. However, in the other two that shared a major histocompatibility complex haplotype, viral mutations were accumulated in a similar order, leading to viral evasion from three epitope-specific CTL responses with viral fitness costs. Accumulation of these multiple escape mutations resulted in the reappearance of plasma viremia around week 60 after challenge. Our results implicate multiple epitope-specific CTL responses in control of immunodeficiency virus replication and furthermore suggest that sequential accumulation of multiple CTL escape mutations, if allowed, can result in viral evasion from this control.

1 June 2009 in Journal of Virology
Verified
Journal Article
Closed access
TYTakuya Yamamoto
Takuya Yamamoto
NINami Iwamoto
Nami Iwamoto
HYHiroyuki Yamamoto
Hiroyuki Yamamoto
TTTetsuo Tsukamoto
Tetsuo Tsukamoto
TKTetsuya Kuwano
Tetsuya Kuwano
TMTetsuro Matano
Tetsuro Matano
Rapid depletion of memory CD4 + T cells and delayed induction of neutralizing antibody (NAb) responses are characteristics of human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV) infections. Although it was speculated that postinfection NAb induction could have only a limited suppressive effect on primary HIV replication, a recent study has shown that a single passive NAb immunization of rhesus macaques 1 week after SIV challenge can result in reduction of viral loads at the set point, indicating a possible contribution of postinfection NAb responses to virus control. However, the mechanism accounting for this NAb-triggered SIV control has remained unclear. Here, we report rapid induction of virus-specific polyfunctional T-cell responses after the passive NAb immunization postinfection. Analysis of SIV Gag-specific responses of gamma interferon, tumor necrosis factor alpha, interleukin-2, macrophage inflammatory protein 1β, and CD107a revealed that the polyfunctionality of Gag-specific CD4 + T cells, as defined by the multiplicity of these responses, was markedly elevated in the acute phase in NAb-immunized animals. In the chronic phase, despite the absence of detectable NAbs, virus control was maintained, accompanied by polyfunctional Gag-specific T-cell responses. These results implicate virus-specific polyfunctional CD4 + T-cell responses in this NAb-triggered virus control, suggesting possible synergism between NAbs and T cells for control of HIV/SIV replication.

15 June 2012 in Journal of Virology
Verified
Journal Article
Closed access
PDF file
TNTakushi Nomura
Takushi Nomura
HYHiroyuki Yamamoto
Hiroyuki Yamamoto
TSTeiichiro Shiino
Teiichiro Shiino
NTNaofumi Takahashi
Naofumi Takahashi
TNTaku Nakane
Taku Nakane
TMTetsuro Matano
Tetsuro Matano
Nonhuman primate AIDS models are essential for the analysis of AIDS pathogenesis and the evaluation of vaccine efficacy. Multiple studies on human immunodeficiency virus and simian immunodeficiency virus (SIV) infection have indicated the association of major histocompatibility complex class I (MHC-I) genotypes with rapid or slow AIDS progression. The accumulation of macaque groups that share not only a single MHC-I allele but also an MHC-I haplotype consisting of multiple polymorphic MHC-I loci would greatly contribute to the progress of AIDS research. Here, we investigated SIVmac239 infections in four groups of Burmese rhesus macaques sharing individual MHC-I haplotypes, referred to as A, E, B, and J. Out of 20 macaques belonging to A+(n= 6), E+(n= 6), B+(n= 4), and J+(n= 4) groups, 18 showed persistent viremia. Fifteen of them developed AIDS in 0.5 to 4 years, with the remaining three at 1 or 2 years under observation. A+animals, including two controllers, showed slower disease progression, whereas J+animals exhibited rapid progression. E+and B+animals showed intermediate plasma viral loads and survival periods. Gag-specific CD8+T-cell responses were efficiently induced in A+animals, while Nef-specific CD8+T-cell responses were in A+, E+, and B+animals. Multiple comparisons among these groups revealed significant differences in survival periods, peripheral CD4+T-cell decline, and SIV-specific CD4+T-cell polyfunctionality in the chronic phase. This study indicates the association of MHC-I haplotypes with AIDS progression and presents an AIDS model facilitating the analysis of virus-host immune interaction.